Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000170835 | SCV000223390 | uncertain significance | not provided | 2014-10-28 | criteria provided, single submitter | clinical testing | p.Pro381Ser (CCC>TCC): c.1141 C>T in exon 8 of the CACNA1C gene (NM_000719.6). The P381S variant in the CACNA1C gene has been reported in an asymptomatic female with a prolonged QTc interval and segregated with disease in two family members with QT prolongation (Fukuyama et al., 2014). However, functional studies did not show any difference in calcium channel characteristics between P381S and wild type (Fukuyama et al., 2014). Additionally, missense mutations in nearby residues have not been reported, indicating this region of the protein may be tolerant of change. Nevertheless, the P381S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, the P381S variant was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in LQT panel(s). |